Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | DAO | P14920 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.39 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29447909 | 1.00 | TAAR1 (0.60) | TAAR1TDP1TSHRACHEDAO | |
| SCHEMBL80278 | 0.86 | TAAR1 (0.56) | TAAR1TDP1TSHRACHEDAO | |
| SCHEMBL8070918 | 0.84 | TAAR1 (0.54) | TAAR1TSHRACHEDAOCA12 | |
| SCHEMBL143962 | 0.84 | TAAR1 (0.71) | TAAR1TSHRACHEDAOCA12 | |
| SCHEMBL8070942 | 0.82 | TAAR1 (0.52) | TAAR1TSHRACHEDAOCA12 | |
| SCHEMBL8063050 | 0.82 | TAAR1 (0.52) | TAAR1TSHRACHEDAOCA12 | |
| SCHEMBL8076478 | 0.82 | TAAR1 (0.52) | TAAR1TSHRACHEDAOCA12 | |
| SCHEMBL8072451 | 0.82 | TAAR1 (0.52) | TAAR1TSHRACHEDAOCA12 | |
| SCHEMBL8072709 | 0.82 | TAAR1 (0.52) | TAAR1TSHRACHEDAOCA12 | |
| SCHEMBL8077937 | 0.82 | TAAR1 (0.52) | TAAR1TSHRACHEDAOCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4492798-A | CARBONYLATION OF ARLALKYL HALIDE WITH CARBON MONOXIDE IN THE PRESE | ETHYL CORPORATION (US) | 1985-01-08 | — | — | US | claimed |
| US-3962357-A | FROM SUBSTITUTED ETHYLTOLUENE, CONTINUOUS, SINGLE STEP | ROHM AND HAAS COMPANY (US) | 1976-06-08 | — | — | US | claimed |
| US-12612380-B2 | Non-lysosomal glucosylceramidase inhibitors and uses thereof | ALECTOS THERAPEUTICS 1NC (CA) | 2026-04-28 | — | — | US | disclosed |
| US-20260109854-A1 | CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2026-04-23 | — | — | US | disclosed |
| US-20260109853-A1 | CURABLE RESIN COMPOSITION AND CURED PRODUCT OF SAME | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2026-04-23 | — | — | US | disclosed |
| US-12595334-B2 | Compound, mixture, curable resin composition and cured product thereof, and method for producing compound | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2026-04-07 | — | — | US | disclosed |
| EP-3966199-B1 | NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF | ALECTOS THERAPEUTICS INC (CA) | 2026-03-18 | — | — | EP | disclosed |
| US-12336991-B2 | Factor XIIA inhibitors | UNIVERSITY OF LEEDS (GB) | 2025-06-24 | — | — | US | disclosed |
| WO-2024253039-A1 | CURABLE RESIN COMPOSITION AND CURED PRODUCT THEREOF | 日本化薬株式会社 | 2024-12-12 | — | — | WO | disclosed |
| WO-2024219273-A1 | CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF | 日本化薬株式会社 | 2024-10-24 | — | — | WO | disclosed |
| WO-2024219272-A1 | CURABLE RESIN COMPOSITION AND CURED PRODUCT OF SAME | 日本化薬株式会社 | 2024-10-24 | — | — | WO | disclosed |
| US-5130321-A | Analgesic n-phenyl-n-(3-or 1-3-me-4-piperidinyl)amides | GLAXO INC. (US) | 1992-07-14 | — | — | US | disclosed |
| US-4690709-A | NONTOXIC AND NONPHYTOTOXIC PHOTOSYNTHESIS INHIBITORS; FUNGICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-09-01 | — | — | US | disclosed |
| US-4633026-A | DEHYDROHALOGENATION OF RING-HALOGENATED ALPHA- OR BETA-BROMOETHYL BENZENES WITH STRONG BASE, POLYOXYETHYLENE GLYCOL CATALYST, AMINE POLYMERIZATION INHIBITOR | ETHYL CORPORATION (US) | 1986-12-30 | — | — | US | disclosed |
| EP-0134216-A4 | PROCESS FOR PREPARING -g(a)-KETO-CARBOXYLIC ACIDS. | ETHYL CORP (US) | 1985-07-01 | — | — | EP | disclosed |
| EP-0134216-A1 | PROCESS FOR PREPARING $g(a)-KETO-CARBOXYLIC ACIDS | ETHYL CORPORATION (US) | 1985-03-20 | — | — | EP | disclosed |
| US-4492798-A | CARBONYLATION OF ARLALKYL HALIDE WITH CARBON MONOXIDE IN THE PRESE | ETHYL CORPORATION (US) | 1985-01-08 | — | — | US | disclosed |
| WO-1984002699-A1 | PROCESS FOR PREPARING alpha-KETO-CARBOXYLIC ACIDS | ETHYL CORP (US) | 1984-07-19 | — | — | WO | disclosed |
| US-4309212-A | POSTEMERGENCE, FUNGICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-01-05 | — | — | US | disclosed |
| US-3962357-A | FROM SUBSTITUTED ETHYLTOLUENE, CONTINUOUS, SINGLE STEP | ROHM AND HAAS COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109854-A1 | CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF | MLLT1, CRBN, POT1 | TAAR1 4109/4885TDP1 1635/4885TSHR 4117/4885 |
| US-12612380-B2 | Non-lysosomal glucosylceramidase inhibitors and uses thereof | GBA1, GBA2, MAN2B1 | TAAR1 3573/4885TDP1 942/4885TSHR 866/4885 |
| US-20260109853-A1 | CURABLE RESIN COMPOSITION AND CURED PRODUCT OF SAME | PSMA1, PSMB10, RAD51 | TAAR1 3193/4885TDP1 1275/4885TSHR 4166/4885 |
| US-12595334-B2 | Compound, mixture, curable resin composition and cured product thereof, and method for producing compound | RER1, RXRA, TERB1 | TAAR1 1618/4885TDP1 2310/4885TSHR 2702/4885 |
| US-12336991-B2 | Factor XIIA inhibitors | F11, F13B, F12 | TAAR1 4644/4885TDP1 1923/4885TSHR 2458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.